References
1. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J,
et al. Carrier testing for severe childhood recessive diseases by
next-generation sequencing. Sci Transl Med. 2011.
2. Hogan GJ, Vysotskaia VS, Beauchamp KA, Seisenberger S, Grauman PV,
Haas KR, et al. Validation of an Expanded Carrier Screen that Optimizes
Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant
Identification. Clinical chemistry. 2018;64(7):1063-73.
3. Johansen Taber KA, Beauchamp KA, Lazarin GA, Muzzey D, Arjunan A,
Goldberg JD. Clinical utility of expanded carrier screening:
results-guided actionability and outcomes. Genetics in medicine :
official journal of the American College of Medical Genetics.
2019;21(5):1041-8.
4. Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F,
et al. Responsible implementation of expanded carrier screening.
European journal of human genetics : EJHG. 2017;25(11):1291.
5. Nazareth SB, Lazarin GA, Goldberg JD. Changing trends in carrier
screening for genetic disease in the United States. Prenatal diagnosis.
2015;35(10):931-5.
6. Committee Opinion No. 690: Carrier Screening in the Age of Genomic
Medicine. Obstetrics and gynecology. 2017;129(3):e35-e40.
7. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
Obstetrics and gynecology. 2017;129(3):e41-e55.
8. Edwards JG, Feldman G, Goldberg J, Gregg AR, Norton ME, Rose NC, et
al. Expanded carrier screening in reproductive medicine-points to
consider: a joint statement of the American College of Medical Genetics
and Genomics, American College of Obstetricians and Gynecologists,
National Society of Genetic Counselors, Perinatal Quality Foundation,
and Society for Maternal-Fetal Medicine. Obstetrics and gynecology.
2015;125(3):653-62.
9. Kraft SA, Duenas D, Wilfond BS, Goddard KAB. The evolving landscape
of expanded carrier screening: challenges and opportunities. Genetics in
medicine : official journal of the American College of Medical Genetics.
2019;21(4):790-7.
10. Lindheim SR, Jaeger AS. Expanded preconception carrier screening in
clinical practice: cutting the Gordian Knot. Fertility and sterility.
2015;104(2):281-2.
11. Gilmore MJ, Schneider J, Davis JV, Kauffman TL, Leo MC, Bergen K, et
al. Reasons for Declining Preconception Expanded Carrier Screening Using
Genome Sequencing. Journal of genetic counseling. 2017;26(5):971-9.
12. Nijmeijer SCM, Conijn T, Lakeman P, Henneman L, Wijburg FA, Haverman
L. Attitudes of the general population towards preconception expanded
carrier screening for autosomal recessive disorders including inborn
errors of metabolism. Molecular genetics and metabolism.
2019;126(1):14-22.
13. Shiroff JJ, Nemeth LS. Public Perceptions of Recessive Carrier
Testing in the Preconception and Prenatal Periods. Journal of obstetric,
gynecologic, and neonatal nursing : JOGNN. 2015;44(6):717-25.
14. Van Steijvoort E, Chokoshvili D, J WC, Peeters H, Peeraer K,
Matthijs G, et al. Interest in expanded carrier screening among
individuals and couples in the general population: systematic review of
the literature. Human reproduction update. 2020;26(3):335-55.
15. Schuurmans J, Birnie E, Ranchor AV, Abbott KM, Fenwick A, Lucassen
A, et al. GP-provided couple-based expanded preconception carrier
screening in the Dutch general population: who accepts the test-offer
and why? European journal of human genetics : EJHG. 2020;28(2):182-92.
16. Zhao S, Xiang J, Fan C, Asan, Shang X, Zhang X, et al. Pilot study
of expanded carrier screening for 11 recessive diseases in China:
results from 10,476 ethnically diverse couples. European journal of
human genetics : EJHG. 2019;27(2):254-62.
17. Xi Y, Chen G, Lei C, Wu J, Zhang S, Xiao M, et al. Expanded carrier
screening in Chinese patients seeking the help of assisted reproductive
technology. Molecular genetics & genomic medicine. 2020:e1340.
18. He WB, Tan YQ, Hu X, Li W, Xiong B, Luo KL, et al. Expanded carrier
screening and preimplantation genetic diagnosis in a couple who
delivered a baby affected with congenital factor VII deficiency. BMC
medical genetics. 2018;19(1):15.
19. Pereira N, Wood M, Luong E, Briggs A, Galloway M, Maxwell RA, et al.
Expanded genetic carrier screening in clinical practice: a current
survey of patient impressions and attitudes. Journal of assisted
reproduction and genetics. 2019;36(4):709-16.
20. Ekstrand Ragnar M, Tyden T, Kihlbom U, Larsson M. Swedish parents’
interest in preconception genetic carrier screening. Upsala journal of
medical sciences. 2016;121(4):289-94.
21. Plantinga M, Birnie E, Abbott KM, Sinke RJ, Lucassen AM, Schuurmans
J, et al. Population-based preconception carrier screening: how
potential users from the general population view a test for 50 serious
diseases. European journal of human genetics : EJHG.
2016;24(10):1417-23.
22. Kauffman TL, Irving SA, Leo MC, Gilmore MJ, Himes P, McMullen CK, et
al. The NextGen Study: patient motivation for participation in genome
sequencing for carrier status. Molecular genetics & genomic medicine.
2017;5(5):508-15.
23. Propst L, Connor G, Hinton M, Poorvu T, Dungan J. Pregnant Women’s
Perspectives on Expanded Carrier Screening. Journal of genetic
counseling. 2018;27(5):1148-56.
24. Spencer S, Ewing S, Calcagno K, O’Neill S. Adopted Individuals’
Views on the Utility and Value of Expanded Carrier Screening. Journal of
genetic counseling. 2018;27(6):1341-8.
25. Chokoshvili D, Belmans C, Poncelet R, Sanders S, Vaes D, Vears D, et
al. Public Views on Genetics and Genetic Testing: A Survey of the
General Public in Belgium. Genetic testing and molecular biomarkers.
2017;21(3):195-201.
26. Li G, Chandrasekharan S, Allyse M. ”The Top Priority Is a Healthy
Baby”: Narratives of Health, Disability, and Abortion in Online
Pregnancy Forum Discussions in the US and China. Journal of genetic
counseling. 2017;26(1):32-9.
27. Shen J. Precision assessment of public attitudes toward genetic
testing. American journal of medical genetics Part A.
2016;170(12):3185-8.
28. Wertz D. Eugenics is alive and well: a survey of genetic
professionals around the world. Science in context.
1998;11(3-4):493-510.
29. Rudan I, Chan KY, Zhang JS, Theodoratou E, Feng XL, Salomon JA, et
al. Causes of deaths in children younger than 5 years in China in 2008.
Lancet (London, England). 2010;375(9720):1083-9.
30. Wang L, Wang Z, Ma Q, Fang G, Yang J. The development and reform of
public health in China from 1949 to 2019. Globalization and health.
2019;15(1):45.
31. Holtkamp K, Mathijssen I, Lakeman P, van Maarle M, Dondorp W,
Henneman L, et al. Factors for successful implementation of
population-based expanded carrier screening: learning from existing
initiatives. 2017;27(2):372-7.
32. Ames AG, Metcalfe SA, Dalton Archibald A, Duncan RE, Emery J.
Measuring informed choice in population-based reproductive genetic
screening: a systematic review. European journal of human genetics :
EJHG. 2015;23(1):8-21.
33. Ong R, Howting D, Rea A, Christian H, Charman P, Molster C, et al.
Measuring the impact of genetic knowledge on intentions and attitudes of
the community towards expanded preconception carrier screening. Journal
of medical genetics. 2018;55(11):744-52.
34. Glanz K, Lewis FM, Rimer BKJM, Sports Si, Exercise. Health Behavior
and Health Education: Theory, Research, and Practice. 1991;23(12):1404.
35. Higgins A, Flanagan JD, Von Wald T, Hansen KAJOJoO, Gynecology. An
Expanded Carrier Screening Tool Enhances Preconception Cystic Fibrosis
Screening in Infertile Couples. 2015;05(7):412-6.
36. Cai W, Wu F. Influence of Income Disparity on Child and Adolescent
Education in China: A Literature Review. New directions for child and
adolescent development. 2019;2019(163):97-113.
37. Shen Y, Qiu X, Gui B, He S, Huang H, Xue J, et al. Implementing
comprehensive genetic carrier screening in China―Harnessing the power of
genomic medicine for the effective prevention/management of birth
defects and rare genetic diseases in China. 2018;2(1):30-6.
38. Chen LS, Goodson P. Factors affecting decisions to accept or decline
cystic fibrosis carrier testing/screening: a theory-guided systematic
review. Genetics in medicine : official journal of the American College
of Medical Genetics. 2007;9(7):442-50.
39. Henneman L, Bramsen I, van der Ploeg HM, ten Kate LP. Preconception
cystic fibrosis carrier couple screening: impact, understanding, and
satisfaction. Genetic testing. 2002;6(3):195-202.
40. Cho D, McGowan ML, Metcalfe J, Sharp RR. Expanded carrier screening
in reproductive healthcare: perspectives from genetics professionals.
Human reproduction (Oxford, England). 2013;28(6):1725-30.
41. Norton ME. Expanded Carrier Screening: A Rational Approach to
Screening for Rare Diseases. Obstetrics and gynecology.
2017;130(2):260-1.
42. Stevens B, Krstic N, Jones M, Murphy L, Hoskovec J. Finding Middle
Ground in Constructing a Clinically Useful Expanded Carrier Screening
Panel. Obstetrics and gynecology. 2017;130(2):279-84.
43. Wienke S, Brown K, Farmer M, Strange C. Expanded carrier screening
panels-does bigger mean better? Journal of community genetics.
2014;5(2):191-8.
44. Chokoshvili D, Vears DF, Borry P. Growing complexity of (expanded)
carrier screening: Direct-to-consumer, physician-mediated, and
clinic-based offers. Best practice & research Clinical obstetrics &
gynaecology. 2017;44:57-67.
45. Kihlbom U. Ethical issues in preconception genetic carrier
screening. Upsala journal of medical sciences. 2016;121(4):295-8.
46. McClaren BJ, Delatycki MB, Collins V, Metcalfe SA, Aitken M. ’It is
not in my world’: an exploration of attitudes and influences associated
with cystic fibrosis carrier screening. European journal of human
genetics : EJHG. 2008;16(4):435-44.